Boxer Capital, LLC’s Achillion Pharmaceuticals In Position
Does Boxer Capital, LLC own Achillion Pharmaceuticals In (ACHNEUR)? Not currently — the last reported position was 3.00M shares worth $18M in Q4 2019; the fund’s latest 13F (Q4 2024) no longer reports it.
Position Value
$18M
Q4 2019
Shares
3.00M
% of Portfolio
+1.03%
Quarters Held
2
position exited
Position History ACHNEUR
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of ACHNEUR.